Foundation Medicine, Inc. Income Statement

Ask AI

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2017 12 months to Dec 31, 2017	FY2016 12 months to Dec 31, 2016	FY2015 12 months to Dec 31, 2015	FY2014 12 months to Dec 31, 2014	FY2013 12 months to Dec 31, 2013
Revenue:
Molecular Information Services
Pharma Research and Development Services
Total revenue
Related-party revenue
Total revenue
Costs and expenses:
Cost of molecular information services
Molecular Information Services
Total cost of molecular information services
Cost of related-party molecular information services from Roche
Selling and marketing
General and administrative
Research and development
Total costs and expenses
Loss from operations
Interest (expense) income, net
Other income
Total other income (expense), net
Net loss
Accretion of redeemable convertible preferred stock
Net loss applicable to common stockholders
Other comprehensive income (loss):
Unrealized gain/(loss) on available-for-sale securities
Foreign currency translation adjustment
Total other comprehensive income (loss)
Comprehensive loss
Net loss per common share, basic and diluted
Weighted-average common shares outstanding, basic and diluted

Comments